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Abstract
Background: Measurement of serum ionized calcium is not always available in practice.
Total calcium (tCa) might not be reliable for determination of calcium status in cats.
Objectives: To predict serum ionized calcium concentration from signalment, bio-
chemistry profile and T4, and compare predicted ionized calcium (piCa) to tCa.
Animals: A total of 1701 cats from two hospitals.
Methods: Cross-sectional study. Cats with serum ionized calcium, biochemistry pro-
file and T4 available were screened over 6 years and included in the training set
(569 cats) to create a multivariate adaptive regression splines model to calculate piCa.
Diagnostic performances of tCa and piCa and its prediction interval (PI) were com-
pared in 652 cats from the same institution (test set) and 480 cats from a different
hospital (external set).
Results: The final model included tCa, chloride, albumin, cholesterol, creatinine, BUN,
body condition score, GGT, age, and potassium. For hypercalcemia, piCa was highly spe-
cific (test set: 99.8%; confidence interval [CI]: 99.5-100; external set: 97%; CI: 95.3-98.7)
but poorly sensitive (test set: 30.4%; CI: 18.3-42.4; external set: 42.5%; CI: 31.7-53.3).
For hypocalcemia, piCa was also highly specific (test set: 81.6%; CI: 78-85; external set:
99.6%; CI: 99-100) but poorly sensitive (test set: 57.6%; CI: 50.6-64.6; external set: 0%).
These diagnostic performances were comparable to those of tCa. The upper and lower
limits of piCa PI had high sensitivity for detecting ionized hypercalcemia and hypocalce-
mia, respectively.
Conclusions and clinical importance: Predicted ionized calcium is useful to confirm
suspected hypercalcemia in cats and screen for hypercalcemia and hypocalcemia.
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1 | INTRODUCTION
There are three fractions of serum total calcium (tCa): ionized, protein-
bound, and complexed calcium. Ionized calcium is the free, biologically
active form of calcium within the blood that is tightly regulated.1 Ion-
ized calcium concentration, measured by analyzers with ion-specific
electrodes, is considered the gold standard for evaluation of calcium
homeostasis in both humans and animals.2 Although the availability of
portable, cost-effective point-of-care analyzers has facilitated measure-
ment of ionized calcium concentration, many veterinary hospitals do
not have immediate access to measured ionized calcium (miCa) and rely
on tCa concentration. Measurement of tCa might not be a reflection of
miCa, especially in cats, and therefore, might not reflect the correct cal-
cium status of the cat.3 Fluctuations in the fractions of tCa might be
responsible for the discordance between tCa and miCa.1 Correction
equations, which adjust the tCa for either albumin or total protein con-
centration, have attempted to improve the correlation between tCa and
miCa. Unfortunately, these corrected tCa formulas are highly unreliable
in cats to predict the ionized calcium status.3 In dogs, a recent study
developed a model for predicting miCa based on numerous values avail-
able on a biochemical profile.4 This model was developed using data
from 1200 dogs and used nonparametric statistics (ie, a multivariate
adaptive regression splines [MARS] model) to determine the relation-
ships between biochemical results and variation of miCa, and to provide
a prediction of ionized calcium concentration. Although this model was
only evaluated with variables measured from a single laboratory, it
showed overall higher performance than tCa and corrected tCa to clas-
sify dogs according to their miCa status.
The objectives of this study were (a) to employ the same statistical
technique as in dogs to create a multivariate predictive model of ion-
ized calcium concentration in cats, using only readily available data
such as signalment, routine biochemistry measurements, and T4
values, and (b) to evaluate the diagnostic performances of predicted
ionized calcium (piCa) using data from two laboratories.
2 | MATERIALS AND METHODS
2.1 | Study population and data collection
A. Predictive model development: Medical records of cats were retro-
spectively reviewed between 2008 and 2016 at the University of Illi-
nois Veterinary Teaching Hospital. Cats were included if they had a
measurement of ionized calcium concentration, a serum biochemistry
panel (creatinine, blood urea nitrogen [BUN], total protein, albumin,
globulin, tCa, phosphorus, sodium, potassium, chloride, glucose, alkaline
phosphatase [ALP], alanine transferase, gamma-glutamyltransferase
[GGT], total bilirubin, cholesterol, triglycerides, and bicarbonate), and a
T4 level, all performed within 24 hours of each other. Cats were
excluded if any laboratory values were missing. Ionized calcium concen-
tration was measured by sampling 0.4 mL of whole blood that was
placed directly into a lithium heparin-coated plastic tube containing <15
USP units of heparin/mL of blood. To ensure proper mixing of blood
with anticoagulant, the tube was inverted 8-10 times and was analyzed
within 15 minutes of collection, according to the manufacturer's recom-
mendations. The blood was withdrawn from the tube using a syringe
and analyzed with a stat blood gas analyzer that uses ion-selective elec-
trode technology (NovaStat CCX, Waltham, Massachusetts). The ion-
ized calcium concentration reported was unadjusted. The reference
interval (RI) for miCa was determined using 31 healthy cats and was
1.14-1.33 mmol/L. The biochemistry panel was obtained from two
chemistry analyzers (Hitachi 917 Automatic Analyzer, Roche Ltd., Basel,
Switzerland from February 2008 to August 2010 and Olympus AU680,
Beckman Coulter, Inc, Brea, California from August 2010 to November
2016 [Table S1]).
The miCa and all values obtained from the biochemistry panel,
including T4, were recorded for each patient. Additional information
such as age, breed, sex, body weight, and body condition score (BCS)5
were also recorded.
B. Assessment of predictive model performance: Both internal vali-
dation (ie, evaluation of the reproducibility of the model on cats from the
same population and same laboratory as those used for model develop-
ment) and external validation (ie, evaluation of the transportability or the
generalizability of the model by cats from different population and labo-
ratory) were assessed. For internal validation, two situations were con-
sidered: if T4 level was eventually retained in the predictive model, no
additional cats would be available for model testing and internal valida-
tion would be performed via 10-fold cross validation using the same cats
as those included for development of the model. If T4 level was not part
of the final predictive model, all cats that fulfilled inclusion criteria except
for T4 level availability would be included to form a test set, on which
the performance of the newly created model would be assessed. From
the authors' point of view, a test set would be preferable over a cross
validation technique, in order to limit overfitting.6
For external validation, a different institution, from a different geo-
graphical area, was contacted for eligibility of their cases (Queen
Mother Hospital for Animals, Royal Veterinary College, London, UK).
Eligibility criteria were the use of a different biochemistry analyzer than
the ones used for model development, and availability of miCa and of
the predictors required for piCa calculation. If only one predictor was
not available, eligibility would still be considered if the missing predictor
had low contribution to the prediction (defined by a generalized cross-
validation statistics [GCV] < 10 in Table 3 and a small range of miCa
variation on the corresponding graph on Figure 1). As the institution ful-
filled eligibility criteria, cats were retrospectively selected from the
Royal Veterinary College database from 2008 to 2018. Ionized calcium
concentration was measured on nonheparinized whole blood immedi-
ately after venipuncture by a point-of-care analyzer (i-STAT 1, Abbott,
Princeton, New Jersey). The unadjusted ionized calcium concentration
was reported. The RI for miCa was determined using 52 healthy cats
>9 years and was 1.19-1.37 mmol/L.7 For the biochemistry panel,
blood was obtained by jugular venipuncture, collected in a heparinized
tube, and stored on ice for a maximum of 6 hours until centrifugation
and separation. Heparinized plasma was sent to an external laboratory
(Idexx laboratories, Wetherby, UK) for analysis with a Beckman coulter
AU50800 analyzer. Time between miCa and tCa measurement was
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approximately 24 hours. GGT was not included in the biochemistry
panel and was arbitrarily set to 0 U/L for all cats, based on the median
GGT value of the cats from the University of Illinois Veterinary Teach-
ing Hospital, which was 0. To guarantee independence of observations,
an individual could not be included more than once; if the cat was eval-
uated several times, only the first evaluation was included. Differences
regarding the demographic data between the training set, the test set
and the external set were assessed by the Mann-Whitney test with
Bonferroni correction and the Chi-square test for continuous and
dichotomous variables, respectively, as continuous data significantly
differed from a Gaussian distribution (assessed via Shapiro-Wilk
test, P < .05).
2.2 | Multivariate adaptive regression splines
predictive model creation
MARS model statistics were performed by the software of the public
domain R version 3.4.2 (R project, Vienna, Austria). A MARS model
was used to create the predictive algorithm in the same way as it was
done in dogs.4,8 Briefly, a MARS model is a nonparametric regression
technique that approximates complex non-linear relationships by a
series of hinge functions of the predictors expressed by the formula:
piCa= a0 +
Xp
k =1
ak*hk xð Þ,
where a0 is the intercept of the model, p is the total number of hinge
functions, ak is the coefficient of the k
th hinge function hk(x), and x is a
predictor. The hinge functions are pairs of two-sided truncated functions
applied to all the predictors and described by the following equations:
h x−tð Þ=
x−tð Þ if x> t
0 if x≤ t
(
h t−xð Þ=
t−xð Þ if x< t
0 if x≥ t
(
where t is the joining point of the polynomial called knot. Therefore, the
hinge functions break each predictor variable into two groups centered
on a knot value and determine a linear relationship between the predic-
tor and miCa in each group. The final relationship between the predic-
tors and miCa is therefore nonlinear. The MARS model selection
followed a two-step process: the initial forward pass selected the full
model, which included all of the biochemical variables that were useful
a priori to predict miCa. Then, multiple backward elimination passes
were used for final model selection and predictive performance optimi-
zation, by removing hinge functions 1 by 1 from the model by all possi-
ble combinations. Each time a variable was removed, the accuracy and
complexity of the new model were assessed by GCV statistics. The
smaller the GCV, the more accurate and less complex the model. The
model with the lowest GCV value was selected as the final model.
Finally, a prediction interval (PI) was defined as follows: piCa ±2x
regression SE.9
2.3 | Description of the relationship between
biochemistry predictors and ionized calcium
concentration
Importance of the independent variables in miCa prediction was
assessed by the GCV criterion, which corresponds to the increase in
GCV when a variable is removed from the model. For ease of interpre-
tation, the increases in GCV were scaled so the largest increase was
100. Variables that caused larger increase in GCV were considered
more important. The predicted relationship between miCa and the
predictors was depicted graphically for each predictor.
F IGURE 1 Individual relationships between measured ionized
calcium and the predictors that have been retained in the final
predictive model. The measured ionized calcium value is represented
on the y-axis, against the value of the predictor variables on the x-axis
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2.4 | Assessment of predictive model performance
For both test and external sets, accuracy of the prediction was mea-
sured by calculating the root mean squared error (RMSE), which can
be interpreted as the average distance between the observed values
and the model prediction. The accuracy of the prediction interval
(PI) was evaluated by measuring how often the miCa values were
included inside the PI.
Samples were classified as hypercalcemic, hypocalcemic, and nor-
mocalcemic if miCa was greater than the upper limit of the RI, lower
than the lower limit of the RI, or in between the two limits of the RI,
respectively. For each set, sensitivity, specificity, and negative (NPV)
and positive predictive values (PPV) were calculated for piCa and its
PI and tCa by logistic regression and predictive margins using STATA
version 14.2 software (StataCorp LLC, College Station, Texas).10 Spec-
ification errors and goodness-of-fit of the logistic regression were
assessed by the linktest and lfit functions of the software. Negative
(NDLR) and positive diagnostic likelihood ratios (PDLR) were directly
calculated from the contingency tables. For all these indices, 95% con-
fidence intervals (CI) were calculated.
2.5 | Comparison between total calcium and
predicted ionized calcium diagnosic performance
The same logistic regression method was applied to determine the diag-
nostic performances of tCa, and of piCa PI lower and upper limits. Per-
formances of piCa and tCa were compared by evaluating the 95% CI of
Sen, Spe, PPV, NPV, PDLR, and NDLR. Significant differences between
piCa and tCa were considered if their 95% CI did not overlap for a same
index. Furthermore, diagnostic discordance was evaluated for piCa and
tCa. Samples for which the calcium status differed when determined by
miCa and piCa (or tCa) were coded with a score of 1 (as opposed to 0 if
there was agreement between miCa and piCa [or tCa]). Diagnostic dis-
cordance and its 95% CI was estimated for piCa and tCa by a logistic
model in which the dependent variable was presence/absence of
diagnostic discordance, and the independent variable was centers
(ie, University of Illinois Veterinary Teaching Hospital or Royal Veterinary
College Queen Mother Hospital for Animals).
3 | RESULTS
3.1 | Study population
In total, 1538 cats met inclusion criteria at the University of Illinois
Veterinary Teaching Hospital, with 317 cats excluded because of
missing values. Among the remaining 1221 cats, 569 had a miCa, a full
biochemistry panel, and a T4 level measured within 24 hours over the
inclusion period, and, therefore, constituted the training set to create
the predictive model. As T4 was not retained in the model (see
Table 2), a test set of 652 cats (ie, all the cats with a miCa and a bio-
chemistry panel but no T4 measurement over the inclusion period)
was created for internal validation. Comparison between the training
and test sets are shown in Table 1. There were significant differences
in age, miCa, tCa, albumin, and chloride levels between the training
and test sets. Prevalence of ionized hypercalcemia was not signifi-
cantly different between the two sets (training set: 7.7%, test set:
8.6%, P = .59), but prevalence of ionized hypocalcemia was (training
set: 19.3%, test set: 29.3%, P < .001).
Four hundred eighty cats from the Royal Veterinary College
Queen Mother Hospital for Animals were included for external valida-
tion. Comparisons between the external set and the training and test
sets are shown in Table 1. There were significant differences in almost
all of the variables evaluated, including prevalence of ionized hyper-
calcemia (external set: 16.7%, training set: 7.7%, P < .001, test set:
8.6%, P < .001), and ionized hypocalcemia (external set: 3.7%, training
set: 19.3%, P < .001, test set: 29.3%, P < .001).
3.2 | Final model
The final model included creatinine, BUN, albumin, tCa, potassium,
chloride, GGT, cholesterol, age, and BCS, and is presented in Table 2.
Appendix 1 shows an example of how to calculate piCa by this model
in cats.
3.3 | Description of the relationship between
biochemistry predictors and ionized calcium
concentration
As shown in Table 3, the most important variables for prediction of
miCa, in descending order, were tCa, chloride, albumin, cholesterol,
creatinine, BUN, BCS, GGT, age, and potassium.
The individual relationships between miCa and the predictor vari-
ables are presented in Figure 1. The miCa increased almost linearly as
tCa increased. In addition, miCa increased as chloride and cholesterol
concentrations increased, but only to a certain point (chloride value of
115 mmol/L and cholesterol value of 76 mg/dL), where the relation-
ships ceased. Conversely, miCa had no change associated with age and
potassium values until a certain value (16 years old and 5.6 mmol/L,
respectively), where miCa increased as age and potassium concentra-
tion increased further.
On the other hand, miCa decreased as BCS, BUN and GGT con-
centrations increased, but only to a certain point (BCS of 4.5, BUN
value of 82 mg/dL, and GGT value of 3 U/L), where the relationships
ceased. Conversely, miCa had no change associated with albumin
values until a certain value (2.7 mg/dL), where miCa decreased as
albumin concentration increased further.
Finally, the most complex association was found between miCa
and creatinine, as miCa increased with increasing creatinine values, up
to a certain point (6.8 mg/dL), but then decreased when creatinine
concentration increased further.
3.4 | Assessment of predictive model performance
and comparison with total calcium
The observed-versus-predicted plots, displaying miCa on the y-axis
and piCa on the x-axis, are presented in Figure 2A,B for the test set
4 HODGSON ET AL.
and the external set, respectively. If miCa and piCa were exactly the
same, all of the points would lay on a single line, which would be the
first bisector (miCa = 0 + 1 × piCa). Points tended to dispersed away
from the first bisector, especially at lower miCa values, indicating a
greater difference between miCa and piCa in ionized hypocalcemic
cats. The average difference between piCa and miCa, as estimated by
RMSE, was 0.1 mmol/L and 0.08 mmol/L in the test set and external
set, respectively. The PI included miCa 78% and 85% of the time in
the test set and external set, respectively.
Sensitivity, specificity, NPV, PPV, NDLR, and PDLR for piCa and its
PI and tCa for diagnosis of ionized hypercalcemia or hypocalcemia are
presented in Table 4A,B, respectively. Unlike tCa, sensitivity of piCa to
detect ionized hypercalcemia was not significantly different between
the test (30.4%; 95% CI: 18.3-42.2) and external sets (42.5%, 95% CI:
31.7-53.3). Owing to the difference in sensitivity of tCa between the
2 sets (test set: 58.9%, 95% CI: 46-71.8; external set: 15%, 95% CI:
7.2-22.8), piCa was significantly less sensitive than tCa in the test set,
but more sensitive than tCa in the external set, to detect ionized
hypercalcemia.
If the upper limit of piCa PI was used to screen for ionized hyper-
calcemia (ie, if the upper limit of piCa PI was >1.33 mmol/L, piCa may
actually be >1.33 mmol/L), sensitivity increased to 69.6% (95% CI:
57.6-81.7) and 97.5% (95% CI: 94.1-100) in the test set and external
set, respectively.
Specificity of piCa and tCa to diagnose ionized hypercalcemia
could only be compared in the test set, as a 95% CI could not be cal-
culated for tCa specificity in the external set because of the absence
of false positive results. In the test set, piCa was significantly more
specific than tCa to diagnose hypercalcemia.
If the lower limit of piCa PI was used to diagnose ionized hypercal-
cemia (ie, if the lower limit of piCa PI was >1.33 mmol/L, piCa must be
>1.33 mmol/L), specificity was 100% in both the test and external sets.
In the test set, the use of piCa and its PI was significantly better
than the use of tCa to diagnose ionized hypercalcemia, as
TABLE 1 Demographic data and selected biochemical variables for the cats of the training set, test set, and external set
Variable Training set (n = 569) Test set (n = 652) P1 External set (n = 480) P2 P3
Age (years) 10.2 (0.2-27) 8.6 (0.2-23.8) <.001 14.7 (0.9-26) <.001 <.001
BCS (9-point scale) 5 (1-9) 5 (1-9) .07 4 (1-9) <.001 <.001
Sex .11 .06 <.001
Neutered males 328 (57.6%) 390 (59.8%) 241 (50.2%)
Intact males 7 (1.2%) 15 (2.3%) 5 (1%)
Spayed females 228 (40.1%) 233 (35.7%) 231 (48.1%)
Intact females 6 (1.1%) 14 (2.2%) 3 (0.7%)
Ionized calcium (mmol/L) 1.22 (0.8-2.3) 1.19 (0.6-1.8) <.001 1.3 (0.9-1.8) <.001 <.001
Ionized hypercalcemia 44 (7.7%) 56 (8.6%) .59 80 (16.7%) <.001 <.001
Ionized hypocalcemia 110 (19.3%) 191 (29.3%) <.001 18 (3.7%) <.001 <.001
Ionized normocalcemia 415 (73%) 405 (62.1%) <.001 382 (79.6%) .01 <.001
Total calcium (mg/dL) 9.6 (6.5-20.7) 9.0 (4.2-13.9) <.001 10.0 (7.6-13.7) <.001 <.001
Total hypercalcemia 107 (18.8%) 77 (11.8%) <.001 12 (2.5%) <.001 <.001
Total hypocalcemia 94 (16.5%) 255 (39.1%) <.001 2 (.4%) <.001 <.001
Total normocalcemia 368 (64.7%) 320 (49.1%) <.001 466 (97.1%) <.001 <.001
Albumin (g/dL) 3.2 (1.5-4.7) 2.9 (0.4-4.5) <.001 3.1 (1.9-4.0) <.001 <.001
Hyperalbuminemia 7 (1.2%) 5 (0.8%) .56 0 (0%) .02 .08
Hypoalbuminemia 127 (22.3%) 313 (48%) <.001 11 (2.3%) <.001 <.001
Normoalbuminemia 435 (76.5%) 334 (51.2%) <.001 469 (97.7%) <.001 <.001
Creatinine (mg/dL) 1.4 (0.2-19.7) 1.3 (0.2-31.5) .06 2.0 (0.6-10.9) <.001 <.001
Normal creatinine 428 (75.2%) 500 (76.7%) .55 230 (48%) <.001 <.001
Creatinine >2.0 mg/dL 141 (24.8%) 152 (23.3%) 250 (52%)
Chloride (mmol/L) 116 (56-137) 115 (67-143) <.001 118 (101-129) <.001 <.001
Hyperchloridemia 12 (2.1%) 13 (2%) .89 15 (3.1%) .30 .23
Hypochloridemia 56 (9.9%) 157 (24.1%) <.001 0 (0%) <.001 <.001
Normochloridemia 501 (88%) 482 (73.9%) <.001 465 (96.9%) <.001 <.001
Note: Table entries represent median values (minimum–maximum) for continuous variables and number of cats (percent of cats) for categorical variables.
Significant differences between two sets were defined by a P < .017 and are bolded. BCS, body condition score; P1: P value for the comparison between
the training and test sets; P2: P value for the comparison between the training and external sets; P3: P value for the comparison between the test and
external sets.
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demonstrated by significantly higher PPV (piCa: 94.4%, 95% CI:
83.9-100; lower limit of PI: 100%; tCa: 42.8%, 95% CI: 31.8-53.9) and
PDLR (piCa: 181, 95% CI: 24-1334; lower limit of PI: ∞; tCa: 8, 95%
CI: 5.6-11.4). Such a comparison was not possible in the external set
because of the lack of false positive hypercalcemia by tCa. However,
the use of piCa and its PI was significantly better than the use of tCa
to exclude ionized hypercalcemia, as demonstrated by significantly
higher NPV (upper limit of PI: 97.9%, 95% CI: 95.1-100; tCa: 85.5%,
95% CI: 82.3-88.7) and significantly lower NDLR (piCa: .6, 95% CI:
.5-.7; upper limit of PI: .1, 95% CI: .05-.4; tCa: .8, 95% CI:.8-.9) in the
external set.
Finally, diagnostic discordance for ionized hypercalcemia between
piCa and miCa varied between the test and the external sets and was
6.1% (95% CI: 4.5-8.2) and 12.1% (95% CI: 9.5-15.3), respectively. It
was slightly lower than the diagnostic discordance between tCa and
miCa, which also varied between the test and the external sets
(10.3%; 95% CI: 8.2-12.9 and 14.2%; 95% CI: 11.3-17.6, respectively).
TABLE 3 Evaluation of the importance of the predictor variables
that form the model for predicting measured ionized calcium changes
Variables in order of
importance (from top to bottom) GCV
Total calcium 100
Chloride 47.2
Albumin 26.4
Cholesterol 13.9
Creatinine 11.9
BUN 9.5
Body condition score 8.8
GGT 6.8
Age 4.6
Potassium 3.1
Abbreviations: BUN, blood urea nitrogen; GGT, gamma
glutamyltransferase.
F IGURE 2 Observed-versus-predicted plot showing the
relationship between measured and predicted ionized calcium in the
(A) test set and (B) external set. The upper and lower limits of
normocalcemia are represented by the vertical dashed lines for the
predicted ionized calcium (1.14-1.33 mmol/L), and the horizontal solid
line for the measured ionized calcium (A: 1.14-1.33 mmol/L;
B: 1.19-1.37 mmol/L). The diagonal dotted line represents the first
bisector, on which predicted ionized calcium values that perfectly
match measured ionized calcium fall in. The thick solid line represents
the regression line. Points that fall within the three gray boxes along
the first bisector were properly classified by predicted ionized
calcium, and those points outside these gray boxes were misclassified
by predicted ionized calcium. miCa, measured ionized calcium;
piCa, predicted ionized calcium
TABLE 2 Final multivariate adaptive regression splines model for
prediction of ionized calcium from routine biochemical and cat
variables determined from the cats of the training set
Hinge function of the predictors Coefficient
(Intercept) 1.32146983
h(6.8-creatinine) −0.01343127
h(creatinine-6.8) −0.01683551
h(82-BUN) 0.00126050
h(Albumin-2.7) −0.06398259
h(11-total calcium) −0.06373329
h(total calcium-11) 0.09763819
h(potassium-5.6) 0.03565030
h(115-Chloride) −0.00476348
h(3-GGT) 0.00999586
h(76-Cholesterol) −0.00990447
h(Age-16) 0.00946669
h(4.5-Body Condition Score) 0.01128579
Abbreviations: BUN, blood urea nitrogen; GGT, gamma
glutamyltransferase; h(), hinge function.
6 HODGSON ET AL.
T
A
B
L
E
4
Se
ns
it
iv
it
y,
sp
ec
if
ic
it
y,
ne
ga
ti
ve
an
d
po
si
ti
ve
pr
ed
ic
ti
ve
va
lu
es
,a
nd
ne
ga
ti
ve
an
d
po
si
ti
ve
di
ag
no
st
ic
lik
el
ih
o
o
d
ra
ti
o
s
o
f
pr
ed
ic
te
d
io
n
iz
ed
ca
lc
iu
m
an
d
it
s
pr
ed
ic
ti
o
n
in
te
rv
al
an
d
to
ta
l
ca
lc
iu
m
fo
r
di
ag
no
si
s
o
f
(A
)h
yp
er
ca
lc
em
ia
in
ca
ts
o
f
th
e
te
st
an
d
ex
te
rn
al
se
ts
(p
re
va
le
nc
e
o
f
hy
pe
rc
al
ce
m
ia
=
8
.6
%
an
d
1
6
.7
%
,r
es
pe
ct
iv
el
y)
,a
n
d
(B
)h
yp
o
ca
lc
em
ia
in
ca
ts
o
f
th
e
te
st
an
d
ex
te
rn
al
se
ts
(p
re
va
le
nc
e
o
f
hy
po
ca
lc
em
ia
=
2
9
.3
%
an
d
3
.7
%
,r
es
pe
ct
iv
el
y)
.S
ta
ti
st
ic
al
ly
si
gn
if
ic
an
t
di
ff
er
en
ce
s
fo
r
th
e
sa
m
e
in
de
x
be
tw
ee
n
th
e
2
se
ts
(ie
,w
it
h
in
th
e
sa
m
e
ro
w
)a
re
in
d
ic
at
ed
b
y
a
.S
ta
ti
st
ic
al
ly
si
gn
if
ic
an
t
di
ff
er
en
ce
s
fo
r
th
e
sa
m
e
in
de
x
be
tw
ee
n
pi
C
a
an
d/
o
r
th
e
lim
it
s
o
f
it
s
P
Ia
nd
tC
a
in
si
de
a
sa
m
e
se
t
(ie
,w
it
hi
n
th
e
sa
m
e
co
lu
m
n)
ar
e
in
di
ca
te
d
by
b
T
es
t
se
t
(n
=
6
5
2
)
E
xt
er
na
ls
et
(n
=
4
8
0
)
Se
ns
it
iv
it
y
Sp
ec
if
ic
it
y
N
P
V
P
P
V
P
D
LR
N
D
LR
Se
ns
it
iv
it
y
Sp
ec
if
ic
it
y
N
P
V
P
P
V
P
D
LR
N
D
LR
(A
)I
o
ni
ze
d
hy
pe
rc
al
ce
m
ia
pi
C
a
>
1
.3
3
m
m
o
l/
L
3
0
.4
%
b
(1
8
.3
-4
2
.4
)
9
9
.8
%
a,
b
(9
9
.5
-1
0
0
)
9
3
.8
%
(9
2
-9
5
.7
)
9
4
.4
%
b
(8
3
.9
-1
0
0
)
1
8
1
b
(2
4
-1
3
3
4
)
.7
(.6
-.
8
)
4
2
.5
%
b
(3
1
.7
-5
3
.3
)
9
7
%
a
(9
5
.3
-9
8
.7
)
8
9
.4
%
(8
6
.5
-9
2
.3
)
7
3
.9
%
(6
1
.2
-8
6
.6
)
1
4
.2 (7
.7
-2
6
)
.6
b
(.5
-.
7
)
U
pp
er
en
d
o
f
P
I
>
1
.3
3
m
m
o
l/
L
6
9
.6
%
a,
b
(5
7
.6
-8
1
.7
)
7
9
.2
%
b
(7
5
.9
-8
2
.5
)
9
6
.5
%
(9
4
.9
-9
8
.2
)
2
3
.9
%
b
(1
7
.4
-3
0
.5
)
3
.3
a,
b
(2
.6
-4
.2
)
.4
(.3
-.
6
)
9
7
.5
%
a,
b
(9
4
.1
-1
0
0
)
2
3
.5
%
(1
9
.4
-2
7
.7
)
9
7
.9
%
b
(9
5
.1
-1
0
0
)
2
0
.3
%
(1
6
.3
-2
4
.3
)
1
.3
a (1
.2
-1
.4
)
.1
b (
.0
5
-.
4
)
Lo
w
er
en
d
o
f
P
I
>
1
.3
3
m
m
o
l/
L
1
6
.1
%
b
(6
.5
-2
5
.7
)
1
0
0
%
(N
E
)
9
2
.7
%
a
(9
0
.7
-9
4
.7
)
1
0
0
%
(N
E
)
∞
(N
E
)
.8
b
(.7
-.
9
)
1
2
.5
%
(5
.3
-1
9
.7
)
1
0
0
%
(N
E
)
8
5
.1
%
a
(8
1
.9
-8
8
.3
)
1
0
0
%
(N
E
)
∞
(N
E
)
.9
(.8
–.
9
)
tC
a
>
1
0
.2
m
g/
dL
(t
es
t)
;
1
1
.8
m
g/
dL
(e
xt
er
na
l)
5
8
.9
%
a,
b
(4
6
-7
1
.8
)
9
2
.6
%
b
(9
0
.5
-9
4
.7
)
9
6
%
a
(9
4
.4
-9
7
.6
)
4
2
.8
%
b
(3
1
.8
-5
3
.9
)
8
b
(5
.6
-1
1
.4
)
.4
a,
b
(.3
-.
6
)
1
5
%
a,
b
(7
.2
-2
2
.8
)
1
0
0
%
(N
E
)
8
5
.5
%
a,
b
(8
2
.3
-8
8
.7
)
1
0
0
%
(N
E
)
∞
(N
E
)
.8
a,
b (.8
-.
9
)
(B
)I
o
ni
ze
d
hy
po
ca
lc
em
ia
pi
C
a
<
1
.1
4
m
m
o
l/
L
5
7
.6
%
(5
0
.6
-6
4
.6
)
8
1
.6
%
a,
b
(7
8
-8
5
)
8
2
.3
%
a
(7
8
.8
-8
5
.8
)
5
6
.4
%
(4
9
.5
-6
3
.4
)
3
.1
(2
.5
-3
.9
)
.5
a
(.4
–.
6
)
0
%
(N
E
)
9
9
.6
%
a
(9
9
-1
0
0
)
9
6
.2
%
a
(9
4
.5
-9
7
.9
)
0
%
(N
E
)
0
(N
E
)
1
a
(1
)
Lo
w
er
en
d
o
f
P
I
<
1
.1
4
m
m
o
l/
L
9
6
.3
%
b
(9
3
.7
-9
9
)
1
6
.1
%
a,
b
(1
2
.7
-1
9
.4
)
9
1
.4
%
(8
5
.3
-9
7
.5
)
3
2
.2
%
a,
b
(2
8
.4
-3
6
.1
)
1
.1
a,
b
(1
.1
-1
.2
)
.2
(.1
-.
5
)
8
3
.3
%
b
(6
6
.1
-1
0
0
)
6
1
.5
%
a
(5
7
-6
5
.9
)
9
8
.9
%
(9
7
.8
-1
0
0
)
7
.8
%
a
(4
-1
1
.5
)
2
.2
a (1
.7
-2
.7
)
.3
(.1
–.
8
)
U
pp
er
en
d
o
f
P
I
<
1
.1
4
m
m
o
l/
L
2
2
.5
%
b
(1
6
.6
-2
8
.4
)
9
5
.7
%
b
(9
3
.8
-9
7
.5
)
7
4
.9
%
a,
b
(7
1
.4
-7
8
.4
)
6
8
.3
%
(5
6
.8
-7
9
.7
)
5
.2
(3
.1
-8
.6
)
.8
b
(.7
-.
9
)
0
%
(N
E
)
1
0
0
%
(N
E
)
9
6
.3
%
a
(9
4
.6
-9
8
)
0
%
(N
E
)
N
E
1
(N
E
)
tC
a
<
8
.8
m
g/
dL
(t
es
t)
;
8
.2
m
g/
dL
(e
xt
er
na
l)
7
0
.2
%
a,
b
(6
3
.7
-7
6
.6
)
7
3
.7
%
b
(6
9
.7
-7
7
.8
)
8
5
.6
%
a
(8
2
.2
-8
9
.1
)
5
2
.5
%
b
(4
6
.4
-5
8
.7
)
2
.7
b (2
.2
-3
.2
)
.4
a,
b
(.3
-.
5
)
1
1
.1
%
a,
b
(0
-2
5
.6
)
1
0
0
%
(N
E
)
9
6
.7
%
a
(9
5
.1
-9
8
.3
)
1
0
0
%
(N
E
)
∞
(N
E
)
.9
a
(.7
-1
)
HODGSON ET AL. 7
Sensitivity of piCa to screen for ionized hypocalcemia could not
be compared between the test and external sets because of the lack
of true positive results in the external set. However, sensitivity of the
lower end of the PI was not significantly different between the two
sets. The lower end of piCa PI was significantly more sensitive than
tCa to detect ionized hypocalcemia in both sets (test set: lower end of
PI: 96.3%, 95% CI: 93.7-99, tCa: 70.2%, 95% CI: 63.7-76.6%; external
set: lower end of PI: 83.3%, 95% CI: 66.1-100, tCa: 11.1%,
95% CI: 0-25.6).
Specificity of piCa to diagnose ionized hypocalcemia was signifi-
cantly lower in the test set compared to the external set. However, it
was significantly more specific than tCa in the test set (piCa: 81.6%,
95% CI: 78-85; tCa: 73.7%, 95% CI: 69.7-77.8), and as specific as tCa
in the external set (piCa: 99.6%, 95% CI: 99-100; tCa: 100%). Predic-
tive values and diagnostic likelihood ratios of piCa and its PI and tCa
were either similar or not comparable owing to the lack of true or
false positive results.
Finally, diagnostic discordance for ionized hypocalcemia between
piCa and miCa varied between the test and the external sets and was
25.5% (95% CI: 22.3-28.9) and 4.2% (95% CI: 2.7-6.4), respectively. It
was not statistically different from the diagnostic discordance between
tCa and miCa, which also varied between the test and the external sets
(27.3%; 95% CI: 24.0-30.9 and 3.3%; 95% CI: 2.1-5.4, respectively).
4 | DISCUSSION
In this study, a MARS model was created to predict serum ionized cal-
cium in cats and was tested in two different datasets, from two differ-
ent countries. The purpose of the study was to calculate piCa by
measurements universally available; the variables included in the
study were all easily obtained and readily available. Similar to the anal-
ogous dog model, the variables that had a major impact on miCa varia-
tions in cats included tCa, albumin, and chloride; however, there was
also variation associated with age, creatinine, and potassium levels.
Unlike in dogs, cholesterol, BUN, BCS, and GGT were also associated
with miCa changes.
For tCa, chloride, and albumin, the relationship with miCa was rela-
tively similar to what was described in dogs.4 A previous study found a
weaker relationship between tCa and albumin in cats compared to
dogs,11 which might explain why miCa was affected only with increased
albumin levels. The lack of correlation between hypoalbuminemia and
miCa in this study might be a reasonable explanation to the inadequacy
of albumin-corrected formulas for calcium in cats. On the other hand,
the relationships between miCa and creatinine, age, and potassium
measurements were different in dogs and cats. In dogs, miCa decreased
as creatinine concentration increased to 5 mg/dL, where it no longer
had an effect on miCa.4 In cats, miCa increased as creatinine con-
centration increased until 6.8 mg/dL. At higher creatinine concentra-
tions, miCa subsequently decreased. This species difference has been
reported in the literature, as cats with chronic kidney disease might
have either ionized hypocalcemia or hypercalcemia whereas dogs
with chronic kidney disease tend to only demonstrate ionized
hypocalcemia.12,13 Kidney disease might be a risk factor for the devel-
opment of ionized hypercalcemia because of decreased glomerular fil-
tration, increased tubular reabsorption, and decreased calcium bone
storage.14 As azotemia progresses in cats, hypocalcemia becomes more
prevalent.12 As creatinine continues to increase, decreased renal cal-
citriol synthesis and phosphorus retention could cause the observed
hypocalcemia.13,15 Ionized hypocalcemia becomes especially prevalent
in uremic cats, as opposed to cats with compensated kidney disease.12
This inverse relationship between increasing BUN and decreasing miCa
was also reflected by our model. Potassium had no effect on miCa in
both cats and dogs until a certain point, where potassium and miCa
decreased linearly in dogs but increased in cats. This positive correlation
between miCa and potassium at high potassium levels is surprising, as
the opposite is typically observed in cats with urethral obstruction.16
Further investigations on the relationship between miCa and potassium
levels in cats are warranted to understand the association found by the
MARS model. Age was inversely correlated with miCa in dogs younger
than 2.27 years old, likely related to skeletal maturation.4 Conversely,
age was not associated with miCa in cats until >16 years old. The
increased calcium in older cats could be the result of systemic illnesses
causing hypercalcemia.17,18 BCS might decrease as a result of illnesses
associated with hypercalcemia, explaining the relationship found by the
MARS model. The slight decrease of miCa while GGT increases could
be attributed to pancreatitis, as GGT can be increased with pancreatitis,
and as such can be associated with fat saponification and calcium
sequestration.19 An increase in calcium might contribute to an increase
in cholesterol by decreasing an enzyme, 7α-hydroxylase, involved in
cholesterol catabolism.20 These numerous complex relationships
between miCa and biochemical measurements illustrate how a simple
equation cannot predict miCa levels adequately.
Although eventually not retained in the predictive model, T4 was
considered as a potential predictor in this study. Thyroid disorders
affect calcium homeostasis in both humans and cats. In humans with
hyperthyroidism there is a shift toward hypercalcemia with many
suspected explanations, including increased bone resorption, increased
renal reabsorption, and altered fractional excretion of calcium.21,22 Con-
versely, in cats, hyperthyroidism is associated with hypocalcemia.23,24
The mechanism for low calcium levels in hyperthyroid cats is unknown
but has been postulated to be secondary to hyperphosphatemia or
because of renal secondary hyperparathyroidism for those with under-
lying chronic kidney disease.23 However, the MARS model did not
retain T4 in our study, which might indicate that the relationship
between hyperthyroidism in cats and miCa might have actually been
confounded by a comorbidity in previous studies (eg, chronic kidney
disease, which is common in hyperthyroid cats).
In this study, a MARS model was utilized for better accuracy.
A MARS model is nonparametric and nonlinear, which supports better
predictive values than classic parametric linear regression.25 Both
internal and external validations were assessed to evaluate the repro-
ducibility and transportability of the model. Internal validation
assesses the validity of the predictive model by the original popula-
tion, and external validation assesses the validity by a different but
related population. In our study, a population of cats from a different
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institution and a new geographical area was used for external valida-
tion. Although there were statistically significant differences in the
diagnostic performances of piCa and its PI between the test and the
external sets, the results can be considered close enough from a clini-
cal point of view to demonstrate generalizability of the predictive
model. The statistical differences were likely because of dissimilarities
in prevalence of ionized hypocalcemia, ionized hypercalcemia, and
azotemia between the two sets. Overall, piCa and its PI behaved simi-
larly in the two sets. For both ionized hypercalcemia and hypocalce-
mia, piCa presented high specificity, PPV and PDLR, which made it
useful to diagnose calcium disorders but not necessarily to detect
them. However, the PI showed high NPV and low NDLR, which indi-
cated good ability to screen for ionized hypercalcemia (for the PI
upper limit) and hypocalcemia (for the PI lower limit). Finally, the PI
also showed high specificity, PPV and PDLR, which permitted diagno-
sis of ionized hypercalcemia (for the PI lower limit) and hypocalcemia
(for the PI upper limit) with greater confidence. Notably, the diagnosis
of ionized hypercalcemia can be considered certain if the lower limit
of the PI is above 1.33 mmol/L, without the need for miCa. However,
for ionized hypocalcemia, the suspicion can be only reinforced if the
upper limit of the PI is below 1.14 mmol/L, as piCa PI does not seem
to be good enough to diagnose ionized hypocalcemia with certainty in
cats and results should be verified by miCa.
As demonstrated in previous studies, our results confirm that rely-
ing on tCa to classify cats as hypercalcemic is problematic mainly
because of a lack of sensitivity.3,26 In other terms, high tCa values in
cats support ionized hypercalcemia, but many cats with ionized hyper-
calcemia do not have high tCa values. Despite statistically significant
differences between piCa and tCa, both showed comparable diagnos-
tic performances regarding ionized hypercalcemia from a clinical point
of view. For hypocalcemia, tCa was moderately sensitive and specific
in the test set, and highly specific but poorly sensitive in the external
set. This difference between the two sets is likely related to the higher
prevalence of renal azotemia in the external set. These results are in
accordance with a previous study.3 Again, despite statistically signifi-
cant differences between piCa and tCa, both showed similar diagnos-
tic performances regarding ionized hypocalcemia from a clinical point
of view, as reflected by similar diagnostic discordance between piCa
and miCa and tCa and miCa. Hence, the main advantage of piCa over
tCa resides in its PI, which allowed high sensitivity, high NPV and low
NDLR for both ionized hypercalcemia (for the PI upper end) and hypo-
calcemia (for the PI lower end) and, therefore, represents a much bet-
ter screening tool than tCa.
There were several limitations to this study, mainly because of its
retrospective nature. Records with absent or missing data were not
included in the analysis, reducing the number of cats available for model
development and testing. Cats' prior conditions or medications might
have been overlooked while obtaining a history and thus not recorded,
which could have affected their calcium homeostasis or other biochemi-
cal variables. Although clinician motives for measuring ionized calcium
cannot be determined for absolutely all cats, miCa was part of the rou-
tine bloodwork requested on most cats at both the University of Illinois
Veterinary Teaching Hospital (where most of the included cats were
cats that entered through the Emergency Room) and the Royal Veteri-
nary College Queen Mother Hospital for Animals (where most of the
cats were azotemic cats), and was not motivated by a disturbance of
tCa or a suspicion of calcium disorders. Another limitation is that two
different biochemical analyzers were utilized during the study time
frame. However, it is unlikely that these had a substantial impact on the
predictive ability of the model, as predictive performance was relatively
stable over the three sets of cats. An additional limitation, because of
the retrospective nature of the study, was that proper handling tech-
nique of the blood samples cannot be ensured. However, the standard
of care at both hospitals strictly enforces proper handling of blood sam-
ples. If proper handling was not performed, then air exposure might
result in a decrease in miCa for example.27 The blood collection meth-
odology was different between the test set, in which miCa was mea-
sured on heparinized blood, and the external set, in which miCa was
measured on non-heparinized blood. Ionized calcium values would be
different in a same cat if measured from heparinized whole blood and
from non-heparinized whole blood.28 However, both values would
hopefully classify the cat similarly regarding its calcium status respec-
tively to the RIs, which would also be different for miCa measured from
heparinized blood and for miCa measured from whole blood. This was
the case in our study, as the RIs of miCa when measured from heparin-
ized blood was 1.14-1.33 mmol/L, whereas it was 1.19-1.37 mmol/L
when measured from whole blood. Hence, although the methodology
was different between the external set and the test set, it should not
impact the calcium status determination in both sets. Furthermore,
prevalence of ionized hypocalcemia was different between the test and
the external sets: only 18 cats had ionized hypocalcemia in the external
set (prevalence: 3.7%) versus 191 cats in the test set (prevalence:
29.3%). The small number of hypocalcemic cats in the external set likely
impacted the diagnostic performance assessment, as reflected by the
large difference in terms of diagnostic discordance between the test set
(diagnostic discordance between piCa or tCa and miCa around 25-27%)
and the external set (diagnostic discordance around 3-4%).
In our study, the training set and the test set were not randomly
extracted from the same population of cats. The cats of both sets are
different in several ways, as those included in the training set all had
T4 measurement performed and were therefore older than the cats of
the test set. Testing a predictive model from a dataset that comes
from a population that is different from the data used to build the
model is called extrapolation, as opposed to interpolation. However,
the cats of the test set should reflect the data to which the model will
be applied in practice. As the cats of the test set corresponded to a
broad and general population of cats, they likely represent an appro-
priate sample for model testing.
The MARS model identified the BCS as a predictor of ionized cal-
cium. As BCS is a subjective measurement, it may add variability to
the prediction. However, BCS has previously been showed to be
repeatable both within scorers and between scorers in cats.5 Hence, if
the BCS is different between two clinicians for the same cat, the dif-
ference should be limited. A one-point difference in BCS would pro-
duce either no change (if both BCS are >4.5) or a minimal change
(±0.01 mmol/L) in piCa value. It would be unlikely for this
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0.01 mmol/L difference to be clinically relevant in practice. Similarly,
the lack of GGT data available for the cats of the external set likely
had a limited impact on piCa calculation, owing to the low contribu-
tion of GGT to the prediction. Indeed, GGT can only produce a maxi-
mal change of ±0.03 mmol/L in piCa value. It would be unlikely that
this change in piCa value resulted in relevant inaccuracies in the cal-
cium status classification of the cats of the external set. However, in
order to get a prediction as accurate as possible in practice, clinicians
are strongly encouraged to include all the predictors, including GGT
value, in the model.
Lastly, other variables such as ionized magnesium could have
influenced calcium homeostasis.29-32 Magnesium was not included in
the study, as it is not readily available to many veterinary practi-
tioners. Inclusion of this variable may have improved the model
performance.
In conclusion, a novel equation was developed that calculates piCa
from readily available signalment and biochemical data points. This
formula may be useful to those who do not have rapid access to miCa
concentration. This piCa may help confirm suspected hypercalcemia
in cats, owing to its high specificity. Its PI may be used to screen
hypercalcemia and hypocalcemia, owing to its high sensitivity, which
represents a compelling advantage over tCa.
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